Literature DB >> 1985116

Activated B lymphocytes from human immunodeficiency virus-infected individuals induce virus expression in infected T cells and a promonocytic cell line, U1.

P Rieckmann1, G Poli, J H Kehrl, A S Fauci.   

Abstract

Freshly isolated B lymphocytes from patients infected with human immunodeficiency virus (HIV), in contrast to B cells from normal controls, were shown to induce viral expression in two cell lines: ACH-2, a T cell line, and U1, a promonocytic cell line, which are chronically infected with HIV, as well as in autologous T cells. In 10 out of 10 HIV-infected individuals with hypergammaglobulinemia, spontaneous HIV-inductive capacity was found with highly purified peripheral blood B cells, whereas peripheral blood or tonsillar B cells from six healthy, HIV-negative donors did not induce HIV expression unless the cells were stimulated in vitro. The induction of HIV expression was observed in direct coculture experiments of B lymphocytes and HIV-infected cells, and could also be mediated by supernatants from cultures of B cells. Significantly higher amounts of interleukin 6 (IL-6) and tumor necrosis factor alpha (TNF-alpha) were detected in the B cell culture supernatants from HIV-infected patients with hypergammaglobulinemia (IL-6: mean = 536 pg/ml; TNF-alpha: mean = 493 pg/ml), as compared with normal uninfected controls (IL-6: mean = 18 pg/ml; TNF-alpha: mean = 23 pg/ml). Antibodies against these cytokines abolished the HIV-inductive capacity of B cells. We conclude that in vivo activated B cells in HIV-infected individuals can upregulate the expression of virus in infected cells by secreting cytokines such as TNF-alpha and IL-6, and, therefore, may play a role in the progression of HIV infection.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1985116      PMCID: PMC2118767          DOI: 10.1084/jem.173.1.1

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  19 in total

1.  Cytokine-induced expression of HIV-1 in a chronically infected promonocyte cell line.

Authors:  T M Folks; J Justement; A Kinter; C A Dinarello; A S Fauci
Journal:  Science       Date:  1987-11-06       Impact factor: 47.728

2.  Immunoregulatory activities of human immunodeficiency virus (HIV) proteins: effect of HIV recombinant and synthetic peptides on immunoglobulin synthesis and proliferative responses by normal lymphocytes.

Authors:  M P Nair; R Pottathil; E P Heimer; S A Schwartz
Journal:  Proc Natl Acad Sci U S A       Date:  1988-09       Impact factor: 11.205

3.  Mechanisms of B cell activation in patients with acquired immunodeficiency syndrome and related disorders. Contribution of antibody-producing B cells, of Epstein-Barr virus-infected B cells, and of immunoglobulin production induced by human T cell lymphotropic virus, type III/lymphadenopathy-associated virus.

Authors:  R Yarchoan; R R Redfield; S Broder
Journal:  J Clin Invest       Date:  1986-08       Impact factor: 14.808

Review 4.  Immunopathogenic mechanisms of HIV infection: cytokine induction of HIV expression.

Authors:  Z F Rosenberg; A S Fauci
Journal:  Immunol Today       Date:  1990-05

5.  Abnormalities of B-cell activation and immunoregulation in patients with the acquired immunodeficiency syndrome.

Authors:  H C Lane; H Masur; L C Edgar; G Whalen; A H Rook; A S Fauci
Journal:  N Engl J Med       Date:  1983-08-25       Impact factor: 91.245

6.  In vitro mutagenesis identifies a region within the envelope gene of the human immunodeficiency virus that is critical for infectivity.

Authors:  R L Willey; D H Smith; L A Lasky; T S Theodore; P L Earl; B Moss; D J Capon; M A Martin
Journal:  J Virol       Date:  1988-01       Impact factor: 5.103

7.  Interleukin 6 induces human immunodeficiency virus expression in infected monocytic cells alone and in synergy with tumor necrosis factor alpha by transcriptional and post-transcriptional mechanisms.

Authors:  G Poli; P Bressler; A Kinter; E Duh; W C Timmer; A Rabson; J S Justement; S Stanley; A S Fauci
Journal:  J Exp Med       Date:  1990-07-01       Impact factor: 14.307

8.  The essential role of B cell stimulatory factor 2 (BSF-2/IL-6) for the terminal differentiation of B cells.

Authors:  A Muraguchi; T Hirano; B Tang; T Matsuda; Y Horii; K Nakajima; T Kishimoto
Journal:  J Exp Med       Date:  1988-02-01       Impact factor: 14.307

9.  Effect of tumor necrosis factor alpha on mitogen-activated human B cells.

Authors:  J H Kehrl; A Miller; A S Fauci
Journal:  J Exp Med       Date:  1987-09-01       Impact factor: 14.307

10.  Production of tumor necrosis factor/cachectin by human B cell lines and tonsillar B cells.

Authors:  S S Sung; L K Jung; J A Walters; W Chen; C Y Wang; S M Fu
Journal:  J Exp Med       Date:  1988-11-01       Impact factor: 14.307

View more
  25 in total

1.  Levels of proinflammatory cytokines in plasma after pneumoccoccal immunization in human immunodeficiency virus type 1-infected patients.

Authors:  H Valdez; S Purvis; R Asaad; I Valerio; B E Sha; A L Landay; M M Lederman
Journal:  Clin Diagn Lab Immunol       Date:  1999-05

2.  Lymphoid organs function as major reservoirs for human immunodeficiency virus.

Authors:  G Pantaleo; C Graziosi; L Butini; P A Pizzo; S M Schnittman; D P Kotler; A S Fauci
Journal:  Proc Natl Acad Sci U S A       Date:  1991-11-01       Impact factor: 11.205

3.  A platelet-activating factor antagonist, RP 55778, inhibits cytokine-dependent induction of human immunodeficiency virus expression in chronically infected promonocytic cells.

Authors:  D Weissman; G Poli; A Bousseau; A S Fauci
Journal:  Proc Natl Acad Sci U S A       Date:  1993-03-15       Impact factor: 11.205

4.  Impaired proliferative capacity and abnormal cytokine profile of naive and memory CD4 T cells from HIV-seropositive patients.

Authors:  A Cayota; F Vuillier; D Scott-Algara; V Feuillie; G Dighiero
Journal:  Clin Exp Immunol       Date:  1992-06       Impact factor: 4.330

5.  Increased expression of interferon-gamma in hyperplastic lymph nodes from HIV-infected patients.

Authors:  M J Boyle; M F Berger; M Tschuchnigg; J E Valentine; B G Kennedy; M Divjak; D A Cooper; J J Turner; R Penny; W A Sewell
Journal:  Clin Exp Immunol       Date:  1993-04       Impact factor: 4.330

6.  Critical role of peripheral blood phagocytes and the involvement of complement in tumour necrosis factor enhancement of passive collagen-arthritis.

Authors:  R A Fava; C Gates; A S Townes
Journal:  Clin Exp Immunol       Date:  1993-11       Impact factor: 4.330

7.  Human immunodeficiency virus type 1 envelope glycoproteins gp120 and gp160 induce interleukin-6 production in CD4+ T-cell clones.

Authors:  N Oyaizu; N Chirmule; Y Ohnishi; V S Kalyanaraman; S Pahwa
Journal:  J Virol       Date:  1991-11       Impact factor: 5.103

8.  Follicular dendritic cells are a major reservoir for human immunodeficiency virus type 1 in lymphoid tissues facilitating infection of CD4+ T-helper cells.

Authors:  H Spiegel; H Herbst; G Niedobitek; H D Foss; H Stein
Journal:  Am J Pathol       Date:  1992-01       Impact factor: 4.307

9.  Transcription of the tumor necrosis factor alpha gene is rapidly induced by anti-immunoglobulin and blocked by cyclosporin A and FK506 in human B cells.

Authors:  A E Goldfeld; E K Flemington; V A Boussiotis; C M Theodos; R G Titus; J L Strominger; S H Speck
Journal:  Proc Natl Acad Sci U S A       Date:  1992-12-15       Impact factor: 11.205

10.  B cell activation and human immunodeficiency virus infection. V. Phenotypic and functional alterations in CD5+ and CD5- B cell subsets.

Authors:  S Indraccolo; M Mion; R Zamarchi; A Veronesi; M L Veronese; M Panozzo; C Betterle; A Barelli; A Borri; A Amadori
Journal:  J Clin Immunol       Date:  1993-11       Impact factor: 8.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.